Skip to content

Gross Profit at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$1.01B+6.9%
NeoGenomics logo
NeoGenomicsNEO
$80.86M+10.4%
Veracyte logo
VeracyteVCYT
$101.16M+27.2%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$21.49M-24.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's gross profit?
Myriad Genetics (MYGN) reported gross profit of $137.6M in Q1 2026.
How has Myriad Genetics's gross profit changed year-over-year?
Myriad Genetics's gross profit increased by 2.5% year-over-year, from $134.2M to $137.6M.
What is the long-term trend for Myriad Genetics's gross profit?
Over 3 years (2022 to 2025), Myriad Genetics's gross profit has grown at a 6.6% compound annual growth rate (CAGR), from $476.4M to $576.6M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.